Cruciferous Sprouts (Broccoli Sprouts) for Anti-Inflammatory

Research suggests that sulforaphane, the bioactive compound abundant in broccoli sprouts, shows promising anti-inflammatory activity across several preclinical studies, particularly in mouse models of inflammatory bowel disease, where sprout-enriched diets were associated with reduced colitis symptoms, greater gut bacterial diversity, and lower levels of inflammation-promoting bacteria — with one study notably finding that gut microbiota appear essential for unlocking this benefit even when cooking has deactivated the plant's own enzymes. A 2023 review further positioned sulforaphane as a candidate for modulating immune responses and reshaping the gut microbiome in the context of IBD, and a meta-analysis found modest short-term improvements in certain inflammatory markers and metabolic indicators among people with schizophrenia taking sulforaphane supplements. However, the current body of evidence is heavily weighted toward animal studies, and the one meta-analysis of human randomized controlled trials was limited by small sample sizes and variability across studies, meaning conclusions about effectiveness in people remain preliminary. Notably, one study found that sulforaphane unexpectedly increased susceptibility to Chlamydia trachomatis infection in human cells, a reminder that the compound's interactions with the immune system are complex and not uniformly beneficial across all contexts.